Humoral and Cell-Mediated Immune Responses of Foxes (Vulpes Vulpes) after Experimental Primary and Secondary Oral Vaccination Using Sag2 and V-Rg Vaccines
[en] Humoral and cell-mediated immune responses of 36 captive foxes to two oral vaccines against rabies currently used for foxes in Europe were studied. The Street Alabama Dufferin (SAD) mutant Gif (SAG2) vaccine has been selected by double mutation from the SAD virus. The vaccinia recombinant virus (V-RG) expresses the rabies glycoprotein. Both vaccines induce similar humoral and cell-mediated responses after primary and secondary oral administration. We observed a typical anamnestic response, although of a limited duration, after the booster vaccination. Therefore, our results suggested that two successive oral vaccination campaigns should not significantly improve the immunisation of foxes. Lymphocyte in vitro proliferative response to the SAD antigen highlighted the presence in blood of a T-cell specific memory 6 months after vaccination. The synthesis of several vulpine cytokines was detected in peripheral blood mononuclear cells (PBMC) stimulated by SAD antigen via reverse transcription polymerase chain amplification. The data showed a concomitant expression of interleukin (IL)-4 and interferon-gamma in PBMC of vaccinated foxes. No change was detected in the level of IL-2, IL-10 and IL-12 synthesis, whereas the pro-inflammatory cytokine tumour necrosis factor-alpha seemed involved in the activation of naive T lymphocytes.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Lambot, Michel ; Université de Liège - ULiège > Faculté de médecine vétérinaire > Immunology–Vaccinology
Blasco, E.; Agence Française de Sécurité Sanitaire des Aliments
Barrat, Jacques; Agence Française de Sécurité Sanitaire des Aliments
Cliquet, Florence; Agence Française de Sécurité Sanitaire des Aliments
Brochier, Bernard; Ministry of Public Health and Environment > Pasteur Institute of Brussels > Rabies
Renders, Caroline; Ministry of Public Health and Environment > Pasteur Institute of Brussels > Rabies
Krafft, Nicolas; Agence Française de Sécurité Sanitaire des Aliments
Bailly, J.; Agence Française de Sécurité Sanitaire des Aliments
Munier, M.; Agence Française de Sécurité Sanitaire des Aliments
Aubert, Michel F.; Agence Française de Sécurité Sanitaire des Aliments
Pastoret, Paul-Pierre ; Université de Liège - ULiège > Faculté de médecine vétérinaire > Immunology–Vaccinology
Language :
English
Title :
Humoral and Cell-Mediated Immune Responses of Foxes (Vulpes Vulpes) after Experimental Primary and Secondary Oral Vaccination Using Sag2 and V-Rg Vaccines
Wandeler A.I. (1991) Oral immunization of wildlife., Baer GM, editor. The Natural History of Rabies, 2nd ed. Boca Raton, FL: CRC Press; 485-503.
Artois M., Guittré C., Thomas I., Leblois H., Brochier B., Barrat J. (1992) Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: A comparison. Vaccine 10:524-528.
Masson E., Cliquet F., Aubert M., Barrat J., Aubert A., Artois M., Schumacher C.L. (1996) Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunisation of foxes in Europe. Vaccine 14:1506-1510.
Pastoret P.P., Brochier B., Blancou J., Artois M., Aubert M.F.A., Kiény M.P., Lecocq J.P., Languet B., Chappuis G., Desmettre P. (1992) Development and deliberate release of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies., Smith GL, Binns MM, editors. Recombinant Poxviruses. Boca Raton, FL: CRC Press; 163-206.
Flamand A., Coulon P., Lafay F., Tuffereau C. (1993) Avirulent mutants of rabies virus and their use as live vaccine. Trends Microbiol 18:317-320.
Kieny M.P., Lathe R., Drillen R., Spehner S., Skory D., Schmitt T., Wiktor T., Koprowski H., Lecocq J.P. (1984) Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature 312:163-166.
Schumacher C.L., Coulon P., Lafay F., Benejean J., Aubert M.F.A., Barrat J., Aubert A., Flamand A. (1993) SAG-2 oral rabies vaccine. Onderstepoort J Vet Res 60:459-462.
Blancou J., Kiény M.P., Lathe R., Lecocq J.P., Pastoret P.P., Soulebot J.P., Desmettre P. (1986) Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 322:373-375.
Müller W.W. (1995) Oral vaccination and high density fox population. Rabies Bull Eur 19:14-15.
Bruyère V., Lemoine S., Aubert M., Melik N. (1996) La vaccination orale des renards contre la rage en 1997 nous concentrons nos efforts sur les zones plus exposées. Bull Epidémiol Mens Rage France 26:1-2.
Bruyère V., Vuillaume P., Cliquet F., Aubert M.F.A. (2000) Oral rabies vaccination of foxes with one or two delayed distributions of SAG2 baits during the spring. Vet Res 31:339-345.
Vuillaume P., Bruyère V., Aubert M. (1998) Comparison of the effectiveness of two protocols of antirabies bait distribution for foxes (Vulpes vulpes). Vet Res 29:537-546.
Masson E., Bruyère-Masson V., Vuillaume P., Lemoyne S., Aubert M. (1999) Rabies oral vaccination of foxes during the summer with the V-RG vaccine bait. Vet Res 30:595-605.
Dietzschold B., Wang H., Rupprecht C.E., Celis E., Tollis M., Ertl H., Heber-Katz E., Koprowski H. (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA 84:9165-9169.
Sharpee R.L., Nelson L.D., Beckenhauer W.H. (1985) Inactivated tissue culture rabies vaccine with three years immunogenicity in dogs and cats., Kuwert E, Merieux C, Koprowski H, Bögel K, editors. Rabies in the Tropics. Berlin: Springer-Verlag; 262-273.
Zanetti C.R., De Franco M.T., Vassào R.C., Pereira C.A., Pereira O.A.C. (1998) Failure of protection induced by a Brazilian vaccine against Brazilian wild rabies viruses. Arch Virol 143:1745-1756.
Xiang Z.Q., Knowles B.B., McCarrick J.W., Ertl H.C.J. (1995) Immune effector mechanisms required for protection to rabies virus. Virology 214:398-404.
Celis E., Dietzschold B., Hoffman K., Koprowski H. (1989) Specificity and genetic of human T lymphocytes reactive with rabies virus., Thraenhart O, et al., editors. Progress in Rabies Control. Kent: Wells Medical Limited; 231-273.
Janot C., Blancou J., Aubert M.F.A. (1982) Immunité à médiation cellulaire du renard vacciné contre la rage. Comp Immun Infect Dis 5:1-3.
Préhaud C., Coulon P., Lafay F., Thiers C., Flamand A. (1988) Antigenic site II of the rabies virus glycoprotein: Structure and role in viral virulence. J Virol 62:1-7.
Blancou J., Artois M., Brochier B., Thomas I., Pastoret P.P., Desmettre P., Languet B., Kiény M.P. (1989) Innocuité et efficacité d'un vaccin antirabique recombinant des virus de la vaccine et de la rage administré par voie orale au renard, au chien et au chat. Ann Rech Vét 20:195-204.
Aubert M.F.A., Blancou J., Barrat J., Artois M., Barrat M.J. (1991) Transmission et pathogénie chez le renard roux de deux isolats à dix ans d'intervalle du virus de la rage vulpine. Ann Rech Vét 22:77-93.
Aubert M.F.A. (1996) Methods for the calculation of titres., Meslin FX, Kaplan M, Koprowski H, editors. Laboratory Techniques in Rabies, 4th ed. Geneva: World Health Organization; 445-459.
Cliquet F., Aubert M., Sagné L. (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 212:79-87.
(1992) Expert committee on rabies. 8th Report, Technical Report Series 824, Geneva: World Health Organization; .
Letesson J.J., Lostrie N., Depelchin A. (1985) Production d'anticorps monoclonaux spécifiques d'isotypes d'immunoglobulines bovines. Ann Med Vet 129:131-141.
Rottman J.B., Freeman E.B., Tonkonogy S., Tompkins M.B. (1995) A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. Vet Immunol Immunopathol 45:1-18.
Kündig T.M., Kalberer C.P., Hengartner H., Zinkernagel R.M. (1993) Vaccination with two different vaccinia recombinant viruses: Long-term inhibition of secondary vaccination. Vaccine 11:1154-1158.
Joffret M.L., Zanetti C., Morgeaux S., Leclerc C., Sureau P., Perrin P. (1991) Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production. Biologicals 19:113-123.
Perrin P., Joffret M.L., Zanetti C., Bourhy H., Gontier C., Fritzell C., Leclerc C., Sureau P. (1991) Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Vaccine 9:549-558.
Celis E., Miller R.W., Wiktor T.J., Dietzschold B., Koprowski H. (1986) Isolation and characterization of human T cell lines and clones reactive to rabies virus: Antigen specificity and production of interferon-?. J Immunol 136:692-697.
King A.A., Turner G.S. (1993) Rabies: A review. J Comp Pathol 108:1-39.
Perrin P., De Franco T., Jallet C., Fouque F., Morgeaux S., Tordo N., Colle J.H. (1996) The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Res Virol 147:289-299.
